US FDA holds off on shutting down Juul sales to review ‘unique scientific issues’

The US Food and Drug Administration (FDA) has temporarily suspended the marketing denial order (MDO) it served on Juul Labs last month demanding the company remove its e-cigarettes from the US market. The administrative stay does not permanently rescind the order.

The federal agency claimed that “there are scientific issues unique to the Juul application warranting additional review”. It added: “All electronic nicotine delivery systems, or ENDS products, including those made by Juul, are required by law to have FDA authorisation to be legally marketed. The stay and the agency’s review does not constitute authorisation to market, sell, or ship Juul products.”


Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us